1. Syndication Title Are There Clinical Trials for Myeloma Patients That Are Refractory to Lenalidomide?

    02:55

    from Patient Power / Added

    39 Plays / / 0 Comments

    In this “Ask the Expert” segment featuring Dr. Robert Orlowski from MD Anderson Cancer Center, Marilynne asks “What clinical trials are available to patients who are refractory to lenalidomide (REVLIMID®)?” Dr. Orlowski first defines “refractory” and goes on to share information about available treatments and clinical trials for myeloma patients that are refractory to REVLIMID. He also shares patient resources for participating in a clinical trial.

    + More details
    • What Influence Do Specific Translocations Have on the Outcomes of Stem Cell Transplant?

      02:05

      from Patient Power / Added

      100 Plays / / 0 Comments

      In this latest “Ask the Expert” segment featuring Dr. Robert Orlowski from MD Anderson Cancer Center, Patient Power community member Marilynne writes, “What influence, if any, do specific translocations have on the outcomes of stem cell transplant?” Dr. Orlowski provides an explanation of how chromosomal abnormalities may impact transplant and what can be done about it.

      + More details
      • Can You Take a Holiday from Maintenance Therapy?

        02:26

        from Patient Power / Added

        218 Plays / / 0 Comments

        In this latest “Ask the Expert” segment featuring Dr. Robert Orlowski from MD Anderson Cancer Center, a patient inquires about a “drug holiday,” wanting to know if it’s okay to stop taking maintenance therapy for a period of time. Dr. Orlowski answers the question and explains the rationale behind maintenance therapy. He then discusses how myeloma progression is monitored.

        + More details
        • Can Clinical Trials Be Available to More Patients?

          02:34

          from Patient Power / Added

          81 Plays / / 0 Comments

          In this multiple myeloma “Ask the Expert” segment featuring Dr. Robert Orlowski from MD Anderson Cancer Center, Patient Power community member Victor asks how clinical trials can be made more available to patients. Dr. Orlowski discusses why the National Cancer Institute has broad requirements for enrollment and lists a number of resources for patients to access clinical trials.

          + More details
          • Make Cancer History

            02:44

            from Hot Dogs Cold Beer / Added

            2 Plays / / 0 Comments

            Draw the Line Through Cancer - Over 100 Central Texans strike through the center of a giant word "Cancer" with 30-foot red line, visually symbolizing the need to eradicate this disease.

            + More details
            • Informatics Challenges in Personalized Cancer Therapy

              54:36

              from School of Biomedical Informatics / Added

              10 Plays / / 0 Comments

              Amber Johnson, PhD Institute for Personalized Cancer Therapy MD Anderson Cancer Center

              + More details
              • Expectations After a Stem Cell Transplant

                03:25

                from Patient Power / Added

                307 Plays / / 0 Comments

                You’ve successfully completed a stem cell transplant as part of your myeloma treatment but what’s next? Multiple myeloma experts Dr. Faith Davies and Dr. Robert Orlowski discuss what to expect after a stem cell transplant, including maintenance therapy and potential complications.

                + More details
                • Advice on Dealing with Neuropathy in Cancer Treatment

                  04:02

                  from Patient Power / Added

                  314 Plays / / 0 Comments

                  A frequent side effect of cancer treatment is neuropathy, but many patients are reluctant to speak up for fear of interrupting their treatment. At a recent patient forum, experts discussed the topic of neuropathy, explained why it’s important to talk with your doctor about what you’re experiencing, and offered tips on how to relieve the pain of neuropathy.

                  + More details
                  • An Expert Explains High-Risk Myeloma

                    03:12

                    from Patient Power / Added

                    261 Plays / / 0 Comments

                    High-risk multiple myeloma can be a frightening term. At a recent town meeting at MD Anderson Cancer Center, Dr. Gareth Morgan from the University of Arkansas for Medical Sciences explained that risk is defined in many different ways. Dr. Morgan tells us which factors are used to determine the level of risk, and what you should keep in mind if you are told your disease is “high-risk.”

                    + More details
                    • Myeloma Therapy: What’s Best for You?

                      04:08

                      from Patient Power / Added

                      312 Plays / / 0 Comments

                      It’s wonderful to have a number of available myeloma treatments, but how do you choose which is best for you? At a recent Patient Power myeloma forum in Houston, Dr. Robert Orlowski from MD Anderson Cancer Center explained the different types of therapies available including how the drugs work and the benefit to patients.

                      + More details

                      What are Tags?

                      Tags

                      Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."